JNJJohnson & Johnson

JNJ Stock Price, Valuation & Chart | Johnson & Johnson

Compare

$255.56+2.28 (+0.90%)

At close · 16 Oct 2026, 08:00 pm

Sector: Healthcare Industry: Drug Manufacturers - General

Overview Financials Dividends Ratios

JNJ Historical price chart

JNJ Key Stats

Market Capitalization615.87B

PE Ratio23.82

EPS10.73

Trading Volume6.37M

Today's High/Low257.55/254.0

Dividend Yield2.07

52 Week High/Low281.07/184.66

Shares Outstanding2.41B

JNJ Financial Statement

JNJ Analyst ratings

JNJ Analysis & performance metrics

JNJ Company profile

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically…

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by…

JNJ Management team

Name

Position

Joseph J. Wolk CPACFO

Executive Vice President & Chief Financial Officer

Darren Snellgrove

Vice President of Investor Relations

Dirk Brinckman

Chief Compliance Officer

Robert J. Decker Jr.

Controller & Chief Accounting Officer

Elizabeth Forminard J.D.

Executive Vice President & Chief Legal Officer

Jennifer L. Taubert

Executive Vice President & Worldwide Chairman of Innovative Medicine

John C. Reed M.D., Ph.D.

Executive Vice President of Innovative Medicine, R&D

Joaquin DuatoCEO

Chief Executive Officer & Chairman

Name

Position

Joseph J. Wolk CPACFO

Executive Vice President & Chief Financial Officer

Darren Snellgrove

Vice President of Investor Relations

Dirk Brinckman

Chief Compliance Officer

Robert J. Decker Jr.

Controller & Chief Accounting Officer

Elizabeth Forminard J.D.

Executive Vice President & Chief Legal Officer

Jennifer L. Taubert

Executive Vice President & Worldwide Chairman of Innovative Medicine

John C. Reed M.D., Ph.D.

Executive Vice President of Innovative Medicine, R&D

Joaquin DuatoCEO

Chief Executive Officer & Chairman

Management Team

Joseph J. Wolk CPACFO

Executive Vice President & Chief Financial Officer

Darren Snellgrove

Vice President of Investor Relations

Dirk Brinckman

Chief Compliance Officer

Robert J. Decker Jr.

Controller & Chief Accounting Officer

Elizabeth Forminard J.D.

Executive Vice President & Chief Legal Officer

Jennifer L. Taubert

Executive Vice President & Worldwide Chairman of Innovative Medicine

John C. Reed M.D., Ph.D.

Executive Vice President of Innovative Medicine, R&D

Joaquin DuatoCEO

Chief Executive Officer & Chairman

Management

Joseph J. Wolk CPACFO

Executive Vice President & Chief Financial Officer

Darren Snellgrove

Vice President of Investor Relations

Dirk Brinckman

Chief Compliance Officer

Robert J. Decker Jr.

Controller & Chief Accounting Officer

Elizabeth Forminard J.D.

Executive Vice President & Chief Legal Officer

Jennifer L. Taubert

Executive Vice President & Worldwide Chairman of Innovative Medicine

John C. Reed M.D., Ph.D.

Executive Vice President of Innovative Medicine, R&D

Joaquin DuatoCEO

Chief Executive Officer & Chairman

Total 8 executives

JNJ Frequently asked questions

What is Johnson & Johnson (JNJ) Stock Price?

Current stock price of Johnson & Johnson (JNJ) stock is $255.56. The stock price is +0.90% higher in the session. The intraday range can be seen from this page. Volume of Johnson & Johnson (JNJ) stock is 6.37M.

Last updated at 16 Oct 2026, 08:00 pm.

Why is the Johnson & Johnson (JNJ) stock price going up or down today?

The stock price of Johnson & Johnson (JNJ) can change with earnings, company news, and overall market sentiment. Johnson & Johnson operates in the Healthcare / Drug Manufacturers - General market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Johnson & Johnson stock expensive at its current price?

Whether Johnson & Johnson looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for JNJ on this page is 23.82. EPS on this page is 10.73. Compare those figures with peers and growth expectations before deciding if the current Johnson & Johnson price is justified.

How has the stock price of Johnson & Johnson (JNJ) performed historically?

Historical performance for Johnson & Johnson (JNJ) is shown on the price chart on this page. Review multi-period moves alongside volume to see how JNJ reacted to past earnings and market events.

Should I buy Johnson & Johnson (JNJ) stock, at this price?

Buying Johnson & Johnson (JNJ) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.